
Understanding Hyperparathyroidism
Hyperparathyroidism occurs when one or more of the four small parathyroid glands in the neck become overactive and produce too much parathyroid hormone (PTH). This hormone normally keeps calcium in the blood within a narrow, healthy range.
When PTH levels rise, calcium is drawn from the bones and retained by the kidneys, raising blood calcium. Over time this can weaken bones, contribute to kidney stones, and cause fatigue, low mood, poor concentration, thirst and muscle aches. Many people have few or no symptoms, which is why diagnosis often begins with a routine blood test.
DIAGNOSTIC PROCEDURES
Essential Tests for Accurate Diagnosis
Confirming hyperparathyroidism relies on a combination of blood work, imaging and bone assessment to establish the cause and guide the right management plan.

Imaging & Localization
Neck ultrasound, sestamibi scans and 4D-CT help pinpoint overactive parathyroid glands, supporting precise planning when surgery is considered.

Biochemical Screening
Blood tests measure serum calcium, parathyroid hormone (PTH), phosphate and vitamin D, alongside kidney function and 24-hour urine calcium, to confirm the diagnosis.

Bone Health Evaluation
DXA bone density scans of the spine, hip and forearm assess fracture risk and the skeletal impact of excess PTH, guiding treatment decisions.
TREATMENT & MANAGEMENT
Clinical Management
Management of hyperparathyroidism is tailored to the severity of calcium elevation, the presence of complications such as osteoporosis or kidney stones, and each patient's overall health. Your specialist will recommend the pathway best suited to you.
PATHWAY 01
Surgical Treatment
Parathyroidectomy is the only definitive cure for primary hyperparathyroidism. It is typically recommended for symptomatic patients or those meeting clinical criteria such as significantly raised calcium, reduced bone density, kidney involvement, or younger age.
- Minimally invasive, focused parathyroidectomy
- Pre-operative localisation imaging (ultrasound, sestamibi, 4D-CT)
- Intra-operative PTH monitoring
- Short recovery, often same-day or overnight stay
PATHWAY 02
Non-Surgical Management
For patients with mild, asymptomatic disease or those for whom surgery carries higher risk, a structured surveillance and medical approach can safely control calcium and protect bone and kidney health.
- Regular monitoring of calcium, PTH and kidney function
- Periodic bone density (DXA) scans
- Medication such as Prolia or bisphosphonates
- Hydration, vitamin D optimisation and lifestyle guidance
SECONDARY HYPERPARATHYROIDISM
Secondary Hyperparathyroidism and vitamin D deficiency
Secondary hyperparathyroidism occurs when the parathyroid glands produce excess parathyroid hormone (PTH) in usually in response to a drop in blood calcium. Unlike primary hyperparathyroidism, the glands themselves behaving normally. The most common cause is vitamin D deficiency or conditions that impair calcium absorption ( eg coeliac disease). Over time, persistently high PTH can weaken bones, cause bone pain and contribute to vascular calcification. Treatment focuses on correcting the underlying cause, including vitamin D replacement, phosphate control, dietary changes and medications such as calcitriol.Â
Dedicated Specialist Care
Concerned about calcium levels or parathyroid function? Arrange an evaluation with Dr Carey to discuss testing and management options.